111 related articles for article (PubMed ID: 11809716)
1. Overexpression of vascular endothelial growth factor-A165 enhances tumor angiogenesis but not metastasis during beta-cell carcinogenesis.
Gannon G; Mandriota SJ; Cui L; Baetens D; Pepper MS; Christofori G
Cancer Res; 2002 Jan; 62(2):603-8. PubMed ID: 11809716
[TBL] [Abstract][Full Text] [Related]
2. Loss of neural cell adhesion molecule induces tumor metastasis by up-regulating lymphangiogenesis.
Crnic I; Strittmatter K; Cavallaro U; Kopfstein L; Jussila L; Alitalo K; Christofori G
Cancer Res; 2004 Dec; 64(23):8630-8. PubMed ID: 15574770
[TBL] [Abstract][Full Text] [Related]
3. Moderate antiangiogenic activity by local, transgenic expression of endostatin in Rip1Tag2 transgenic mice.
Schaffhauser B; Veikkola T; Strittmatter K; Antoniadis H; Alitalo K; Christofori G
J Leukoc Biol; 2006 Oct; 80(4):669-76. PubMed ID: 16793908
[TBL] [Abstract][Full Text] [Related]
4. Differential vascular and transcriptional responses to anti-vascular endothelial growth factor antibody in orthotopic human pancreatic cancer xenografts.
Bockhorn M; Tsuzuki Y; Xu L; Frilling A; Broelsch CE; Fukumura D
Clin Cancer Res; 2003 Sep; 9(11):4221-6. PubMed ID: 14519649
[TBL] [Abstract][Full Text] [Related]
5. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis.
Maruyama Y; Ono M; Kawahara A; Yokoyama T; Basaki Y; Kage M; Aoyagi S; Kinoshita H; Kuwano M
Cancer Res; 2006 Jun; 66(12):6233-42. PubMed ID: 16778198
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.
Huh JI; Calvo A; Stafford J; Cheung M; Kumar R; Philp D; Kleinman HK; Green JE
Oncogene; 2005 Jan; 24(5):790-800. PubMed ID: 15592523
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.
Middeke M; Hoffmann S; Hassan I; Wunderlich A; Hofbauer LC; Zielke A
Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):386-92. PubMed ID: 12518248
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor-A(165) induces progression of melanoma brain metastases without induction of sprouting angiogenesis.
Küsters B; Leenders WP; Wesseling P; Smits D; Verrijp K; Ruiter DJ; Peters JP; van Der Kogel AJ; de Waal RM
Cancer Res; 2002 Jan; 62(2):341-5. PubMed ID: 11809675
[TBL] [Abstract][Full Text] [Related]
9. Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner.
Guleng B; Tateishi K; Ohta M; Kanai F; Jazag A; Ijichi H; Tanaka Y; Washida M; Morikane K; Fukushima Y; Yamori T; Tsuruo T; Kawabe T; Miyagishi M; Taira K; Sata M; Omata M
Cancer Res; 2005 Jul; 65(13):5864-71. PubMed ID: 15994964
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of vascular endothelial growth factor isoforms drives oxygenation and growth but not progression to glioblastoma multiforme in a human model of gliomagenesis.
Sonoda Y; Kanamori M; Deen DF; Cheng SY; Berger MS; Pieper RO
Cancer Res; 2003 Apr; 63(8):1962-8. PubMed ID: 12702589
[TBL] [Abstract][Full Text] [Related]
11. Angiopoietin-1 and -2 exert antagonistic functions in tumor angiogenesis, yet both induce lymphangiogenesis.
Fagiani E; Lorentz P; Kopfstein L; Christofori G
Cancer Res; 2011 Sep; 71(17):5717-27. PubMed ID: 21778249
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor-trap suppresses tumorigenicity of multiple pancreatic cancer cell lines.
Fukasawa M; Korc M
Clin Cancer Res; 2004 May; 10(10):3327-32. PubMed ID: 15161686
[TBL] [Abstract][Full Text] [Related]
13. Reduced expression of neural cell adhesion molecule induces metastatic dissemination of pancreatic beta tumor cells.
Perl AK; Dahl U; Wilgenbus P; Cremer H; Semb H; Christofori G
Nat Med; 1999 Mar; 5(3):286-91. PubMed ID: 10086383
[TBL] [Abstract][Full Text] [Related]
14. TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis.
Müller-Hermelink N; Braumüller H; Pichler B; Wieder T; Mailhammer R; Schaak K; Ghoreschi K; Yazdi A; Haubner R; Sander CA; Mocikat R; Schwaiger M; Förster I; Huss R; Weber WA; Kneilling M; Röcken M
Cancer Cell; 2008 Jun; 13(6):507-18. PubMed ID: 18538734
[TBL] [Abstract][Full Text] [Related]
15. A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis.
Casanova ML; Larcher F; Casanova B; Murillas R; Fernández-Aceñero MJ; Villanueva C; Martínez-Palacio J; Ullrich A; Conti CJ; Jorcano JL
Cancer Res; 2002 Jun; 62(12):3402-7. PubMed ID: 12067982
[TBL] [Abstract][Full Text] [Related]
16. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression.
Shang ZJ; Li JR
J Oral Pathol Med; 2005 Mar; 34(3):134-9. PubMed ID: 15689226
[TBL] [Abstract][Full Text] [Related]
17. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
[TBL] [Abstract][Full Text] [Related]
18. Selective blockade of vascular endothelial growth factor receptor 2 with an antibody against tumor-derived vascular endothelial growth factor controls the growth of human pancreatic adenocarcinoma xenografts.
Holloway SE; Beck AW; Shivakumar L; Shih J; Fleming JB; Brekken RA
Ann Surg Oncol; 2006 Aug; 13(8):1145-55. PubMed ID: 16791450
[TBL] [Abstract][Full Text] [Related]
19. Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in beta3-integrin-deficient mice.
Reynolds AR; Reynolds LE; Nagel TE; Lively JC; Robinson SD; Hicklin DJ; Bodary SC; Hodivala-Dilke KM
Cancer Res; 2004 Dec; 64(23):8643-50. PubMed ID: 15574772
[TBL] [Abstract][Full Text] [Related]
20. A bioluminescent mouse model of pancreatic {beta}-cell carcinogenesis.
Zumsteg A; Strittmatter K; Klewe-Nebenius D; Antoniadis H; Christofori G
Carcinogenesis; 2010 Aug; 31(8):1465-74. PubMed ID: 20530553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
